ReviewBritish journal of pharmacology2018

Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.

Song-Yang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.